$1.06
-0.17 (-13.82%)
HIT News30 articles
Berkshire Exits UnitedHealth Stake, Stock Faces Monday Pressure
Berkshire Hathaway's disclosure that it sold its UnitedHealth stake in Q1 sent shares down 1.31% to $393.85, with after-hours trading at $375.46. The stock faces Monday pressure.
Berkshire Exits UnitedHealth; Optum AI Monitoring Revealed
Berkshire Hathaway exited its UnitedHealth stake in Q1, reversing a position that had boosted sentiment. UnitedHealth also monitors Optum staff AI tool usage as it expands technology.
P3 Health Partners Soars 200% After First Profit, Lifts 2026 Forecast
P3 Health Partners shares surged over 200% to $13 after posting its first quarterly profit and raising its 2026 adjusted EBITDA outlook. Net income reached $3 million, reversing a $44.2 million loss a year earlier.
Oscar Health Shares Surge as Focus Shifts to Margin Strength
Oscar Health shares rose 7.9% to $23.73 late Tuesday as investors prioritized strong profit margins over a Q1 revenue miss, with the medical loss ratio improving to 70.5%.
UnitedHealth Shares Surge as Investors Bet on Recovery, PBM Reform
UnitedHealth shares climbed 3.1% as the company unveiled a new Optum Rx fee-based pricing model and raised 2026 profit guidance, signaling a potential turnaround.
3D Systems Soars 28% on Q1 Beat, Healthcare Turnaround Gains Traction
3D Systems stock jumped 28% to $3.22 after Q1 revenue and adjusted EPS beat estimates, with healthcare revenue up 21%.
Hims & Hers Health Faces GLP-1 Pivot Ahead of Q1 Earnings
Hims & Hers Health shares surged 10.2% ahead of Q1 earnings, as investors watch the company's pivot from compounded to branded GLP-1 drugs amid FDA regulatory changes.
UnitedHealth Stock Rebounds on Easing Medical Costs and Raised Outlook
UnitedHealth shares rose 2.8% to $379.98, extending gains on easing medical-cost pressures. Q1 revenue hit $111.7B, and the company raised its full-year adjusted earnings outlook above $18.25/share.
Hims & Hers Health Gears for Earnings Amid Weight-Loss Drug Shifts
Hims & Hers Health shares surged 9.3% to $28.03 ahead of its May 11 earnings report, with options pricing a 14.8% move. The company is navigating FDA rules on compounded weight-loss drugs.
Agilon Health Stock Surges 118% on Q1 Profit Beat, New CEO Appointed
Agilon Health shares jumped 118% to $60.66 after a strong Q1 earnings beat, with net income rising to $49M. The company also raised its 2026 forecast and appointed Tim O'Rourke as CEO.
UnitedHealth Eases Prior Authorization Rules; UNH Shares Gain
UnitedHealth Group shares climbed 1% after the company announced it will eliminate prior authorization for 30% of services by 2026, including outpatient surgeries and diagnostic tests.
Oscar Health Shares Surge 5% as Q1 Profit Doubles, 2026 Forecast Maintained
Oscar Health reported Q1 net income of $679M, more than double last year, with revenue up 53% to $4.65B. Shares rose 5.3% as the company reaffirmed its 2026 guidance.
CVS Health Upgrades 2026 Profit View as Aetna Cost Controls Boost Q1 Results
CVS Health raised its 2026 profit outlook after a strong Q1, with revenue topping $100 billion and Aetna's medical benefit ratio improving to 84.6%. Shares surged 9%.
Option Care Health Slumps 28% on Lowered 2026 Revenue View, Chronic Therapy Woes
Option Care Health shares fell 28% after the company lowered its 2026 revenue guidance and reported first-quarter sales that missed Wall Street expectations, citing chronic therapy headwinds.
GE HealthCare Cuts 2026 Profit View on Rising Costs, Stock Plunges
GE HealthCare cut its 2026 profit forecast as rising chip, oil, and freight costs, along with tariffs, squeezed margins. Shares fell nearly 13%.
FTSE 100 Slides as Healthcare Stocks Weigh Despite Earnings Beats
The FTSE 100 slipped 0.6% as healthcare giants AstraZeneca and GSK declined despite topping profit forecasts, while Lloyds Banking Group's profit jump failed to lift sentiment.
UnitedHealth, Health Insurers Rally on Centene Profit Outlook Boost
UnitedHealth Group shares rose about 4% Tuesday after Centene lifted its profit outlook, fueling hopes that medical-cost pressures are easing for major insurers.
HCA Healthcare Shares Slide on Patient Volume Concerns Despite Earnings Beat
HCA Healthcare shares dropped 8.8% after first-quarter profit narrowly beat estimates, but weaker patient volumes and payer-mix concerns rattled investors.
Tempus AI Partners with USC Health System, Unlocking Access to 1.5 Million Annual Visits
Tempus AI Inc. partners with USC's Keck School of Medicine to deploy its molecular testing and trial-matching platform across a health system seeing 1.5 million patient visits each year.
Amazon's GLP-1 Launch Pressures Hims & Hers, Telehealth Rivals
Shares of Hims & Hers Health dropped Tuesday after Amazon launched a GLP-1 weight-management program, heightening competition in the telehealth sector. The company is pivoting from compounded drugs to FDA-approved branded medications.
FDA Peptide Review Sparks Rally for Hims & Hers Health
Shares of Hims & Hers Health climbed sharply after regulators signaled a review of peptide restrictions, a development analysts view as a positive shift for the company's growth strategy.
Snapchat Study Aims to Capture Healthcare Ad Dollars Amid Rival Pressure
Snap Inc. published a study indicating 59% of surveyed Snapchat users altered real-world health actions after seeing content on the platform. The move targets healthcare advertising as the company faces pressure from activist investor Irenic Capital.
UnitedHealth Shares Rally on Medicare Advantage Rate Decision Ahead of Q1 Report
UnitedHealth Group shares advanced following a finalized 2.48% increase to 2027 Medicare Advantage payment rates, which exceeds initial projections. The company is set to report first-quarter results on April 21 amid expectations for an earnings decline.
SCHD ETF Boosts Healthcare in Rebalance as Dividend Fund Inflows Surge
The Schwab U.S. Dividend Equity ETF (SCHD) increased its healthcare allocation to 18.5% during its yearly portfolio update, adding Abbott Laboratories and UnitedHealth Group. The fund gathered nearly $4 billion in the first quarter as investors poured a total of $24.1 billion into U.S. dividend-focused funds, marking the strongest quarterly start since 2022.
UnitedHealth Shares Drop Ahead of Q1 Report, Sector Under Pressure
UnitedHealth Group shares declined sharply Friday, extending weekly losses as the market anticipates first-quarter results. The health insurance sector broadly retreated.
Welltower Retreats as Rate Hike Jitters Rattle Healthcare REITs
Shares of healthcare real estate investment trust Welltower declined sharply as rising bond yields and shifting Federal Reserve expectations pressured the sector. The stock closed significantly below a recent peak.
Bradesco Shareholders Approve Major Capital Boost Ahead of Healthcare Vote
Banco Bradesco secured shareholder approval for a 6.67 billion reais capital increase, raising its stock capital to 93.77 billion reais. The move precedes a crucial March 31 vote on restructuring its healthcare operations.
Bradesco Shareholders Approve Capital Increase, Eye Healthcare Restructuring
Banco Bradesco secured shareholder approval for a R$6.67 billion capital boost through reserve capitalization, leaving its ADR price unchanged. Investors now await a key March 31 vote on consolidating healthcare assets under Odontoprev.
Amazon Faces Key Week After Service Outage, Healthcare AI Launch
Amazon resolved a significant U.S. shopping outage that contributed to a stock decline, while its AWS unit introduced a new AI platform for healthcare. Market focus shifts to upcoming inflation data.
Bradesco Consolidates Health Assets into $52B Bradsaúde Ahead of March Vote
Banco Bradesco will combine its health and dental assets into a new publicly traded entity named Bradsaúde, targeting R$52 billion in 2025 revenue. The proposal requires shareholder approval on March 31.